SG11202104178TA - Peptides and pharmaceutical compositions for treating eye diseases - Google Patents
Peptides and pharmaceutical compositions for treating eye diseasesInfo
- Publication number
- SG11202104178TA SG11202104178TA SG11202104178TA SG11202104178TA SG11202104178TA SG 11202104178T A SG11202104178T A SG 11202104178TA SG 11202104178T A SG11202104178T A SG 11202104178TA SG 11202104178T A SG11202104178T A SG 11202104178TA SG 11202104178T A SG11202104178T A SG 11202104178TA
- Authority
- SG
- Singapore
- Prior art keywords
- peptides
- pharmaceutical compositions
- eye diseases
- treating eye
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Immunology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862767180P | 2018-11-14 | 2018-11-14 | |
| PCT/IB2019/001220 WO2020099925A2 (en) | 2018-11-14 | 2019-11-14 | Peptides and pharmaceutical compositions for treating eye diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202104178TA true SG11202104178TA (en) | 2021-05-28 |
Family
ID=70732068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202104178TA SG11202104178TA (en) | 2018-11-14 | 2019-11-14 | Peptides and pharmaceutical compositions for treating eye diseases |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP3880690A4 (en) |
| JP (1) | JP2022507404A (en) |
| KR (1) | KR20210087539A (en) |
| CN (1) | CN113474356A (en) |
| AU (1) | AU2019378162A1 (en) |
| BR (1) | BR112021009341A2 (en) |
| CA (1) | CA3119921A1 (en) |
| MX (1) | MX2021005077A (en) |
| SG (1) | SG11202104178TA (en) |
| TW (1) | TW202031675A (en) |
| WO (1) | WO2020099925A2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018281617B2 (en) * | 2017-05-17 | 2022-06-30 | Yuyu Pharma, Inc. | Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| KR102662922B1 (en) * | 2022-05-31 | 2024-05-03 | 주식회사 세네릭스 | Novel D-amino acid derivatives and compositions comprising the same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| KR101690539B1 (en) * | 2015-07-30 | 2016-12-29 | 주식회사 아이바이오코리아 | Pharmaceutical composition for preventing or treating dry eye |
| WO2017175963A1 (en) * | 2016-04-08 | 2017-10-12 | 주식회사 아이바이오코리아 | Chondrocyte extracellular matrix-derived peptide |
| KR101795653B1 (en) * | 2016-05-19 | 2017-11-09 | 인제대학교 산학협력단 | Composition for inhibiting angiogenesis comprising chimeric protein of collagen type II peptide-Aflibercept |
| KR20180074928A (en) * | 2016-12-26 | 2018-07-04 | 주식회사 아이바이오코리아 | Animal medicine composition for preventing or treating dry eye |
| AU2018281617B2 (en) * | 2017-05-17 | 2022-06-30 | Yuyu Pharma, Inc. | Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient |
-
2019
- 2019-11-13 TW TW108141290A patent/TW202031675A/en unknown
- 2019-11-14 MX MX2021005077A patent/MX2021005077A/en unknown
- 2019-11-14 WO PCT/IB2019/001220 patent/WO2020099925A2/en unknown
- 2019-11-14 BR BR112021009341-9A patent/BR112021009341A2/en unknown
- 2019-11-14 EP EP19883897.1A patent/EP3880690A4/en active Pending
- 2019-11-14 CN CN201980078779.XA patent/CN113474356A/en active Pending
- 2019-11-14 KR KR1020217018226A patent/KR20210087539A/en unknown
- 2019-11-14 AU AU2019378162A patent/AU2019378162A1/en active Pending
- 2019-11-14 CA CA3119921A patent/CA3119921A1/en active Pending
- 2019-11-14 SG SG11202104178TA patent/SG11202104178TA/en unknown
- 2019-11-14 JP JP2021526304A patent/JP2022507404A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW202031675A (en) | 2020-09-01 |
| BR112021009341A2 (en) | 2021-08-10 |
| CN113474356A (en) | 2021-10-01 |
| JP2022507404A (en) | 2022-01-18 |
| MX2021005077A (en) | 2021-08-11 |
| WO2020099925A2 (en) | 2020-05-22 |
| WO2020099925A3 (en) | 2020-06-25 |
| EP3880690A4 (en) | 2023-09-13 |
| KR20210087539A (en) | 2021-07-12 |
| CA3119921A1 (en) | 2020-05-22 |
| EP3880690A2 (en) | 2021-09-22 |
| AU2019378162A1 (en) | 2021-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276464A (en) | Methods and compositions for therapeutic protein delivery | |
| ZA202004025B (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
| HK1258588A1 (en) | Compounds and formulations for treating ophthalmic diseases | |
| PL3577135T3 (en) | A pharmaceutical composition for use in the treatment or prevention of c5-related diseases | |
| IL275777A (en) | Improved peptide pharmaceuticals for treatment of nash and other disorders | |
| EP3238736A4 (en) | Peptide for treating ocular diseases and composition for treating ocular diseases comprising same | |
| SG11201912110YA (en) | Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient | |
| PL3452075T3 (en) | Ophthalmic pharmaceutical composition | |
| IL272601A (en) | Pharmaceutical compositions for the treatment of ophthalmic conditions | |
| IL279397A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
| EP3192875A4 (en) | Sustained-release pharmaceutical composition for treating and preventing ophthalmic diseases | |
| SG11202104178TA (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| IL287796A (en) | Compositions and methods for the treatment of atpase-mediated diseases | |
| IL284344A (en) | Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease | |
| IL286767A (en) | Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease | |
| EP3713553A4 (en) | Compositions and methods for treatment of eye diseases | |
| EP3768095A4 (en) | Compositions and methods for treating diarrheal diseases | |
| EP3691654A4 (en) | Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease | |
| PT3810128T (en) | Compositions for treating and/or preventing protein-aggregation diseases | |
| PL3515409T3 (en) | Complex and compositions for the treatment of ophthalmic and dermatological diseases | |
| ZA202107235B (en) | Compositions and methods for treating ocular disease | |
| KR102316727B9 (en) | Pharmaceutical composition for preventing or treating atopic diseases | |
| SG11202005278PA (en) | Compounds for treating eye diseases and methods thereof | |
| IL280952A (en) | Methods and compositions for drugs to treat ophthalmic diseases | |
| GB201720101D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases |